{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T23:18:13Z","timestamp":1787699893273,"version":"build-2784847793"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"vor","delay-in-days":70,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100006260","name":"Rheumatology Research Foundation","doi-asserted-by":"publisher","award":["Scientist Development Award"],"award-info":[{"award-number":["Scientist Development Award"]}],"id":[{"id":"10.13039\/100006260","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["T32 AR07534"],"award-info":[{"award-number":["T32 AR07534"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["P30 AR079369"],"award-info":[{"award-number":["P30 AR079369"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["P30 AR079369"],"award-info":[{"award-number":["P30 AR079369"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["R01 AR076450"],"award-info":[{"award-number":["R01 AR076450"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["K23 HL138131"],"award-info":[{"award-number":["K23 HL138131"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"DOI":"10.1186\/s13075-026-03845-3","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T01:43:06Z","timestamp":1781660586000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Sputum lautropia is decreased in rheumatoid arthritis-associated pulmonary fibrosis"],"prefix":"10.1186","volume":"28","author":[{"given":"Timothy M.","family":"Wilson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendan","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Kirk","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristine A.","family":"Kuhn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin D.","family":"Deane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen M.","family":"Humphries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce S.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua J.","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Kristen","family":"Demoruelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,17]]},"reference":[{"issue":"2","key":"3845_CR1","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1183\/13993003.00357-2015","volume":"47","author":"JJ Solomon","year":"2016","unstructured":"Solomon JJ, Chung JH, Cosgrove GP, Demoruelle MK, Fernandez-Perez ER, Fischer A, et al. Predictors of mortality in rheumatoid arthritis-associated interstitial lung disease. Eur Respir J. 2016;47(2):588\u201396.","journal-title":"Eur Respir J"},{"issue":"6","key":"3845_CR2","doi-asserted-by":"publisher","first-page":"983","DOI":"10.3899\/jrheum.101133","volume":"38","author":"E Myasoedova","year":"2011","unstructured":"Myasoedova E, Crowson CS, Turesson C, Gabriel SE, Matteson EL. Incidence of extraarticular rheumatoid arthritis in Olmsted County, Minnesota, in 1995\u20132007 versus 1985\u20131994: a population-based study. J Rheumatol. 2011;38(6):983\u20139.","journal-title":"J Rheumatol"},{"issue":"8","key":"3845_CR3","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1016\/j.rmed.2013.05.002","volume":"107","author":"JJ Solomon","year":"2013","unstructured":"Solomon JJ, Ryu JH, Tazelaar HD, Myers JL, Tuder R, Cool CD, et al. Fibrosing interstitial pneumonia predicts survival in patients with rheumatoid arthritis-associated interstitial lung disease (RA-ILD). Respir Med. 2013;107(8):1247\u201352.","journal-title":"Respir Med"},{"issue":"1","key":"3845_CR4","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1186\/s12931-025-03404-5","volume":"26","author":"KS Knudsen","year":"2025","unstructured":"Knudsen KS, Husebo G, Nielsen R, Paytuvi-Gallart A, Malinverni R, Sanseverino W, et al. Whole genome sequencing of the pulmonary microbiome in interstitial lung disease subtypes. Respir Res. 2025;26(1):324.","journal-title":"Respir Res"},{"issue":"9","key":"3845_CR5","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1164\/rccm.201809-1650OC","volume":"199","author":"DN O\u2019Dwyer","year":"2019","unstructured":"O\u2019Dwyer DN, Ashley SL, Gurczynski SJ, Xia M, Wilke C, Falkowski NR, et al. Lung Microbiota Contribute to Pulmonary Inflammation and Disease Progression in Pulmonary Fibrosis. Am J Respir Crit Care Med. 2019;199(9):1127\u201338.","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"3845_CR6","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/S2213-2600(14)70069-4","volume":"2","author":"MK Han","year":"2014","unstructured":"Han MK, Zhou Y, Murray S, Tayob N, Noth I, Lama VN, et al. Lung microbiome and disease progression in idiopathic pulmonary fibrosis: an analysis of the COMET study. Lancet Respir Med. 2014;2(7):548\u201356.","journal-title":"Lancet Respir Med"},{"issue":"4","key":"3845_CR7","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1183\/13993003.01406-2015","volume":"47","author":"Z Wang","year":"2016","unstructured":"Wang Z, Bafadhel M, Haldar K, Spivak A, Mayhew D, Miller BE, et al. Lung microbiome dynamics in COPD exacerbations. Eur Respir J. 2016;47(4):1082\u201392.","journal-title":"Eur Respir J"},{"issue":"1","key":"3845_CR8","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41392-023-01722-y","volume":"9","author":"R Li","year":"2024","unstructured":"Li R, Li J, Zhou X. Lung microbiome: new insights into the pathogenesis of respiratory diseases. Signal Transduct Target Ther. 2024;9(1):19.","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"3845_CR9","doi-asserted-by":"publisher","first-page":"240167","DOI":"10.1183\/20734735.0167-2024","volume":"21","author":"SG Mikhail","year":"2025","unstructured":"Mikhail SG, O\u2019Dwyer DN. The lung microbiome in interstitial lung disease. Breathe (Sheff). 2025;21(2):240167.","journal-title":"Breathe (Sheff)"},{"issue":"11","key":"3845_CR10","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s11926-020-00960-1","volume":"22","author":"TM Wilson","year":"2020","unstructured":"Wilson TM, Trent B, Kuhn KA, Demoruelle MK. Microbial Influences of Mucosal Immunity in Rheumatoid Arthritis. Curr Rheumatol Rep. 2020;22(11):83.","journal-title":"Curr Rheumatol Rep"},{"issue":"7","key":"3845_CR11","doi-asserted-by":"publisher","first-page":"e29781","DOI":"10.1002\/jmv.29781","volume":"96","author":"Y Xing","year":"2024","unstructured":"Xing Y, Liu Y, Sha S, Zhang Y, Dou Y, Liu C, et al. Multikingdom characterization of gut microbiota in patients with rheumatoid arthritis and rheumatoid arthritis-associated interstitial lung disease. J Med Virol. 2024;96(7):e29781.","journal-title":"J Med Virol"},{"issue":"668","key":"3845_CR12","doi-asserted-by":"publisher","first-page":"eabn5166","DOI":"10.1126\/scitranslmed.abn5166","volume":"14","author":"ME Chriswell","year":"2022","unstructured":"Chriswell ME, Lefferts AR, Clay MR, Hsu AR, Seifert J, Feser ML, et al. Clonal IgA and IgG autoantibodies from individuals at risk for rheumatoid arthritis identify an arthritogenic strain of Subdoligranulum. Sci Transl Med. 2022;14(668):eabn5166.","journal-title":"Sci Transl Med"},{"issue":"1","key":"3845_CR13","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s40168-016-0206-x","volume":"4","author":"JU Scher","year":"2016","unstructured":"Scher JU, Joshua V, Artacho A, Abdollahi-Roodsaz S, Ockinger J, Kullberg S, et al. The lung microbiota in early rheumatoid arthritis and autoimmunity. Microbiome. 2016;4(1):60.","journal-title":"Microbiome"},{"issue":"1","key":"3845_CR14","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1148\/radiol.2017161177","volume":"285","author":"SM Humphries","year":"2017","unstructured":"Humphries SM, Yagihashi K, Huckleberry J, Rho BH, Schroeder JD, Strand M, et al. Idiopathic Pulmonary Fibrosis: Data-driven Textural Analysis of Extent of Fibrosis at Baseline and 15-Month Follow-up. Radiology. 2017;285(1):270\u20138.","journal-title":"Radiology"},{"issue":"Pt 1","key":"3845_CR15","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1099\/00221287-148-1-257","volume":"148","author":"MA Nadkarni","year":"2002","unstructured":"Nadkarni MA, Martin FE, Jacques NA, Hunter N. Determination of bacterial load by real-time PCR using a broad-range (universal) probe and primers set. Microbiol (Reading). 2002;148(Pt 1):257\u201366.","journal-title":"Microbiol (Reading)"},{"key":"3845_CR16","doi-asserted-by":"publisher","first-page":"40114","DOI":"10.1038\/srep40114","volume":"7","author":"H Mizrahi","year":"2017","unstructured":"Mizrahi H, Peretz A, Lesnik R, Aizenberg-Gershtein Y, Rodriguez-Martinez S, Sharaby Y, et al. Comparison of sputum microbiome of legionellosis-associated patients and other pneumonia patients: indications for polybacterial infections. Sci Rep. 2017;7:40114.","journal-title":"Sci Rep"},{"key":"3845_CR17","doi-asserted-by":"publisher","first-page":"e4","DOI":"10.1017\/gmb.2022.12","volume":"4","author":"AK Sulit","year":"2023","unstructured":"Sulit AK, Kolisnik T, Frizelle FA, Purcell R, Schmeier S. MetaFunc: taxonomic and functional analyses of high throughput sequencing for microbiomes. Gut Microbiome (Camb). 2023;4:e4.","journal-title":"Gut Microbiome (Camb)"},{"key":"3845_CR18","doi-asserted-by":"publisher","first-page":"1176044","DOI":"10.3389\/fimmu.2023.1176044","volume":"14","author":"E Goeteyn","year":"2023","unstructured":"Goeteyn E, Grassi L, Van den Bossche S, Rigauts C, Vande Weygaerde Y, Van Braeckel E, et al. Commensal bacteria of the lung microbiota synergistically inhibit inflammation in a three-dimensional epithelial cell model. Front Immunol. 2023;14:1176044.","journal-title":"Front Immunol"},{"key":"3845_CR19","doi-asserted-by":"publisher","unstructured":"Rigauts C, Aizawa J, Taylor SL, Rogers GB, Govaerts M, Cos P et al. R othia mucilaginosa is an anti-inflammatory bacterium in the respiratory tract of patients with chronic lung disease. Eur Respir J. 2022;59(5). https:\/\/doi.org\/10.1183\/13993003.01293-2021.","DOI":"10.1183\/13993003.01293-2021"},{"key":"3845_CR20","doi-asserted-by":"publisher","first-page":"107277","DOI":"10.1016\/j.phrs.2024.107277","volume":"206","author":"Y Wang","year":"2024","unstructured":"Wang Y, Li L, Chen S, Yu Z, Gao X, Peng X, et al. Faecalibacterium prausnitzii-derived extracellular vesicles alleviate chronic colitis-related intestinal fibrosis by macrophage metabolic reprogramming. Pharmacol Res. 2024;206:107277.","journal-title":"Pharmacol Res"},{"issue":"1","key":"3845_CR21","doi-asserted-by":"publisher","first-page":"e0262767","DOI":"10.1371\/journal.pone.0262767","volume":"17","author":"P Kanmani","year":"2022","unstructured":"Kanmani P, Kim H. Probiotics counteract the expression of hepatic profibrotic genes via the attenuation of TGF-beta\/SMAD signaling and autophagy in hepatic stellate cells. PLoS ONE. 2022;17(1):e0262767.","journal-title":"PLoS ONE"},{"key":"3845_CR22","doi-asserted-by":"publisher","unstructured":"Lombardi F, Augello FR, Palumbo P, Mollsi E, Giuliani M, Cimini AM et al. Soluble Fraction from Lysate of a High Concentration Multi-Strain Probiotic Formulation Inhibits TGF-beta1-Induced Intestinal Fibrosis on CCD-18Co Cells. Nutrients. 2021;13(3). https:\/\/doi.org\/10.3390\/nu13030882.","DOI":"10.3390\/nu13030882"},{"issue":"3","key":"3845_CR23","doi-asserted-by":"publisher","first-page":"e0230667","DOI":"10.1371\/journal.pone.0230667","volume":"15","author":"J Alam","year":"2020","unstructured":"Alam J, Lee A, Lee J, Kwon DI, Park HK, Park JH, et al. Dysbiotic oral microbiota and infected salivary glands in Sjogren\u2019s syndrome. PLoS ONE. 2020;15(3):e0230667.","journal-title":"PLoS ONE"},{"issue":"11","key":"3845_CR24","doi-asserted-by":"publisher","first-page":"111352","DOI":"10.1016\/j.celrep.2022.111352","volume":"40","author":"X Wang","year":"2022","unstructured":"Wang X, Pang K, Wang J, Zhang B, Liu Z, Lu S, et al. Microbiota dysbiosis in primary Sjogren\u2019s syndrome and the ameliorative effect of hydroxychloroquine. Cell Rep. 2022;40(11):111352.","journal-title":"Cell Rep"},{"issue":"18","key":"3845_CR25","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1056\/NEJMoa1908681","volume":"381","author":"KR Flaherty","year":"2019","unstructured":"Flaherty KR, Wells AU, Cottin V, Devaraj A, Walsh SLF, Inoue Y, et al. Nintedanib in Progressive Fibrosing Interstitial Lung Diseases. N Engl J Med. 2019;381(18):1718\u201327.","journal-title":"N Engl J Med"},{"key":"3845_CR26","doi-asserted-by":"publisher","first-page":"724033","DOI":"10.3389\/fphar.2021.724033","volume":"12","author":"CS Cruz","year":"2021","unstructured":"Cruz CS, Ricci MF, Vieira AT. Gut Microbiota Modulation as a Potential Target for the Treatment of Lung Infections. Front Pharmacol. 2021;12:724033.","journal-title":"Front Pharmacol"},{"key":"3845_CR27","doi-asserted-by":"publisher","first-page":"115662","DOI":"10.1016\/j.addr.2025.115662","volume":"225","author":"KE Hern","year":"2025","unstructured":"Hern KE, Prindle A. Towards airway microbiome engineering for improving respiratory health. Adv Drug Deliv Rev. 2025;225:115662.","journal-title":"Adv Drug Deliv Rev"},{"issue":"13","key":"3845_CR28","doi-asserted-by":"publisher","first-page":"3528","DOI":"10.1016\/j.celrep.2018.08.090","volume":"24","author":"V Le Noci","year":"2018","unstructured":"Le Noci V, Guglielmetti S, Arioli S, Camisaschi C, Bianchi F, Sommariva M, et al. Modulation of Pulmonary Microbiota by Antibiotic or Probiotic Aerosol Therapy: A Strategy to Promote Immunosurveillance against Lung Metastases. Cell Rep. 2018;24(13):3528\u201338.","journal-title":"Cell Rep"},{"issue":"18","key":"3845_CR29","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1001\/jama.2021.4956","volume":"325","author":"FJ Martinez","year":"2021","unstructured":"Martinez FJ, Yow E, Flaherty KR, Snyder LD, Durheim MT, Wisniewski SR, et al. Effect of Antimicrobial Therapy on Respiratory Hospitalization or Death in Adults With Idiopathic Pulmonary Fibrosis: The CleanUP-IPF Randomized Clinical Trial. JAMA. 2021;325(18):1841\u201351.","journal-title":"JAMA"},{"issue":"1","key":"3845_CR30","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1186\/s12931-021-01839-0","volume":"22","author":"CY Chen","year":"2021","unstructured":"Chen CY, Chen CH, Wang CY, Lai CC, Chao CM, Wei YF. The effect of additional antimicrobial therapy on the outcomes of patients with idiopathic pulmonary fibrosis: a systematic review and meta-analysis. Respir Res. 2021;22(1):243.","journal-title":"Respir Res"},{"issue":"22","key":"3845_CR31","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.1001\/jama.2020.22960","volume":"324","author":"AM Wilson","year":"2020","unstructured":"Wilson AM, Clark AB, Cahn T, Chilvers ER, Fraser W, Hammond M, et al. Effect of Co-trimoxazole (Trimethoprim-Sulfamethoxazole) vs Placebo on Death, Lung Transplant, or Hospital Admission in Patients With Moderate and Severe Idiopathic Pulmonary Fibrosis: The EME-TIPAC Randomized Clinical Trial. JAMA. 2020;324(22):2282\u201391.","journal-title":"JAMA"},{"issue":"3","key":"3845_CR32","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1128\/JCM.02918-14","volume":"53","author":"G Dubourg","year":"2015","unstructured":"Dubourg G, Abat C, Rolain JM, Raoult D. Correlation between sputum and bronchoalveolar lavage fluid cultures. J Clin Microbiol. 2015;53(3):994\u20136.","journal-title":"J Clin Microbiol"}],"container-title":["Arthritis Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-026-03845-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-026-03845-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-026-03845-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T22:58:07Z","timestamp":1787698687000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13075-026-03845-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,17]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3845"],"URL":"https:\/\/doi.org\/10.1186\/s13075-026-03845-3","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,17]]},"assertion":[{"value":"25 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All study procedures were approved by the Colorado Institutional Review Board and in compliance with the Helsinki Declaration. Written informed consent was obtained from all subjects.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"MKD has received research funding support from Boehringer Ingelheim, Pfizer, Gilead Sciences, Bristol Myers Squibb, and Merck. MKD has served on advisory boards for Merck, Boehringer Ingelheim, and Immunovant. KDD has received research funding support from Pfizer and Boehringer Ingelheim. All other authors have declared that no conflicts of interest exist for this work.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"156"}}